Skip to content

EMERGE HEALTH INTERNATIONAL INC: financial reference

Explore EMERGE HEALTH INTERNATIONAL INC financial histories from SEC filings, with original units, reporting periods, filing dates and downloadable source data.

Filing record ends 2021-09-30

The latest filing in this captured record is a 10-K filed 2021-09-30. No later filing is in the SEC companyfacts record captured on 2026-09-22. EMERGE HEALTH INTERNATIONAL INC may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Reported financial histories

Choose a measure to inspect its definition, complete selected history and filing provenance. Each row shows the latest period available for that selected concept and original unit. Separate currencies and reporting intervals remain separate rows. Coverage dates can differ between concepts. A recent capture does not imply recent accounting coverage; these amounts are not prices.

Latest periods by selected concept and original unit
MeasurePeriod startPeriod endValueUnitFiled
Total assets-2019-06-3027,041USD2021-09-30
Total liabilities-2017-06-30293,719USD2019-03-12
Stockholders equity-2019-06-30-438,811USD2021-09-30
Cash and cash equivalents-2019-06-3017,291USD2021-09-30
Net income or loss2018-07-012019-06-30-2,354,516USD2021-09-30
Capital expenditure payments2017-07-012018-06-30-31,116USD2019-08-28
Revenue2018-07-012019-06-300USD2021-09-30
Financing cash flow2018-07-012019-06-3057,568USD2021-09-30
Investing cash flow2018-07-012019-06-309,013USD2021-09-30
Retained earnings or deficit-2019-06-30-4,846,814USD2021-09-30
Basic weighted-average shares2018-07-012019-06-3017,797,685shares2021-09-30
Basic earnings per share2017-07-012018-06-30-0.03USD/shares2019-08-28
Income tax expense or benefit2018-07-012019-06-300USD2021-09-30
Net property, plant and equipment-2019-06-309,750USD2021-09-30
Operating income or loss2018-07-012019-06-30-2,326,810USD2021-09-30
Current assets-2019-06-3017,291USD2021-09-30
Current liabilities-2019-06-30465,852USD2021-09-30
Current accounts payable-2019-06-3038,852USD2021-09-30
Operating expenses2018-07-012019-06-3091,217USD2021-09-30
Net inventory-2018-06-30439,649USD2019-08-28
Gross profit2018-07-012019-06-300USD2021-09-30
Cost of revenue2018-07-012019-06-300USD2021-09-30
Research and development expense2018-07-012019-06-302,235,593USD2021-09-30
Common shares outstanding-2019-06-3023,367,647shares2021-09-30
Additional paid-in capital-2019-06-304,384,636USD2021-09-30
Gross property, plant and equipment-2019-06-309,750USD2021-09-30
Accumulated depreciation on property, plant and equipment-2019-06-300USD2021-09-30
Accrued current liabilities-2014-06-3019,225USD2014-09-30
General and administrative expense2013-07-012014-06-30828,758USD2014-09-30
Depreciation expense2017-07-012018-06-3026,054USD2019-08-28
Other nonoperating income or expense2017-07-012018-06-304,170USD2019-08-28
Nonoperating income or expense2017-07-012018-06-30-21,465USD2019-08-28
Current income tax expense or benefit2013-07-012014-06-30-56,855USD2014-09-30
Deferred income tax expense or benefit2014-07-012015-06-30930USD2015-10-19
Change in accounts receivable2017-07-012018-06-30233,776USD2021-09-30
Change in inventories2017-07-012018-06-30541,944USD2021-09-30
Change in accounts payable2018-07-012019-06-30-38,852USD2021-09-30

Filings

32 EMERGE HEALTH INTERNATIONAL filings with published measures: what each annual or quarterly report tagged, with the periods it covered, as reported in that filing. The histories above show the latest-filed value per period.

Inspect the source

Entity
EMERGE HEALTH INTERNATIONAL INC / CIK 0000032567
Captured
SEC response SHA-256
ccc4af770e79b095a8863560b1e3ccab7d296bc5e1172eb71ea3e8a8cfe03817

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000032567.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))